
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **TMEM64**: Involved in osteoclast differentiation and bone resorption.<br>- **IFI27, IFITM1, IFI6, ISG15**: Interferon-induced genes, often associated with immune response and antiviral activity.<br>- **GSTM3**: Part of the glutathione S-transferase family, involved in detoxification.<br>- **HSPB1**: Heat shock protein, involved in stress response and protein folding.<br>- **COX6A1, COX6C, MT-CO2, MT-CYB, ATP5F1E, NDUFS8**: Mitochondrial genes involved in oxidative phosphorylation and energy production.<br>- **UBE2C**: Ubiquitin-conjugating enzyme, involved in protein degradation.<br>- **ADRM1**: Involved in proteasome function and protein degradation.<br>- **ROMO1**: Involved in mitochondrial reactive oxygen species production.<br>- **TFF3**: Trefoil factor, involved in mucosal protection and repair.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, including luminal epithelial cells in breast tissue.<br>- **AGR2**: Associated with secretory epithelial cells, often found in breast tissue.<br>- **CST6**: Cystatin, involved in inhibiting cysteine proteases, expressed in epithelial cells.<br>- **SLC39A6**: Zinc transporter, associated with epithelial cells.<br>- **BCAS4**: Breast carcinoma amplified sequence, associated with breast cancer cells.<br>- **STARD10**: Involved in lipid transport, associated with breast cancer.<br>- **TFF3**: Also associated with epithelial cells, particularly in the gastrointestinal tract and breast tissue.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, the markers KRT18, KRT8, KRT19, AGR2, and SLC39A6 are strongly associated with luminal epithelial cells in breast tissue. These markers are commonly used to identify luminal epithelial cells in breast cancer studies.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT18, KRT8, KRT19) and other epithelial markers (AGR2, SLC39A6), the most probable general cell type is **luminal epithelial cells**. These cells are a major component of breast tissue and are often involved in breast cancer.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal A Breast Cancer Cells**: Characterized by high expression of luminal markers and often associated with hormone receptor positivity.<br>2. **Luminal B Breast Cancer Cells**: Similar to Luminal A but with higher proliferation markers like UBE2C.<br>3. **Normal Luminal Epithelial Cells**: Non-cancerous luminal cells, but less likely given the cancer context.<br><br>The most likely subtype based on the markers is **Luminal A Breast Cancer Cells**, due to the presence of luminal markers and the context of breast cancer tissue.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of keratins (KRT18, KRT8, KRT19) and other epithelial markers (AGR2, SLC39A6) strongly indicates a luminal epithelial origin. Within this general cell type, the most probable subtype is Luminal A Breast Cancer Cells, characterized by the expression of luminal markers and the context of breast cancer.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency**: <br>   - The key markers used in the annotation, such as KRT18, KRT8, KRT19, AGR2, and SLC39A6, are present in the provided marker list. These markers are well-known for their association with luminal epithelial cells, particularly in breast tissue.<br>   - The presence of other markers like UBE2C, which is associated with higher proliferation, supports the identification of Luminal B Breast Cancer Cells as a potential subtype, but the context and marker expression lean more towards Luminal A Breast Cancer Cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The analysis does not strongly suggest the presence of multiple distinct cell types. The markers predominantly support the identification of luminal epithelial cells, specifically Luminal A Breast Cancer Cells, which is consistent with the context of breast cancer tissue.<br>   - There is no strong evidence of mixed cell types that would necessitate further investigation.<br><br>Overall, the annotation aligns well with the marker list and the context provided, leading to a valid conclusion of Luminal A Breast Cancer Cells as the most probable cell type.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">luminal epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal A Breast Cancer Cells</li><li>Luminal B Breast Cancer Cells</li><li>Normal Luminal Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its relevance to breast cancer tissue. The analysis correctly identifies the main cell type as luminal epithelial cells, which is consistent with the expression of key markers such as KRT18, KRT8, KRT19, AGR2, and SLC39A6. These markers are well-documented in the literature as being associated with luminal epithelial cells in breast tissue, particularly in the context of breast cancer.<br><br>The annotation also effectively distinguishes between potential subtypes, identifying Luminal A Breast Cancer Cells as the most probable subtype. This conclusion is supported by the presence of luminal markers and the context of breast cancer, which is a reasonable interpretation given the data. The consideration of Luminal B Breast Cancer Cells and Normal Luminal Epithelial Cells as other possible subtypes adds depth to the analysis, although the emphasis remains on Luminal A due to the marker expression and context.<br><br>One strength of the annotation is its balanced consideration of multiple markers. The analysis does not overly focus on a single marker but instead integrates information from various markers, including those involved in immune response, oxidative phosphorylation, and protein degradation. This comprehensive approach helps capture the general picture of the cell populations present.<br><br>However, there are a few areas for improvement. The annotation could benefit from a more explicit discussion of the rank and importance of each marker, particularly those that appear earlier in the list, as these may carry more weight in the analysis. Additionally, while the annotation does not suggest mixed cell types, a more detailed exploration of potential heterogeneity within the cell population could provide a more nuanced understanding.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present, with a few minor areas for enhancement in terms of marker ranking and potential cell type heterogeneity.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    